BIO-11006

DB14886InvestigationalSmall molecule

BIO-11006 is under investigation in clinical trial NCT03202394 (Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS).

Mechanism: Pharmacologically active on Myristoylated alanine-rich C-kinase substrate
Curator reviewed
Formula / weight: C₄₆H₇₅N₁₃O₁₅ · 1050.182 g/mol (avg)
Code names: BIO-11006

Resolves to

Compound

UNII609AWV0US2CAS901117-03-1

Structure

InChIKeyKCSNGWMKFYVMKF-HGYIIGRXSA-NSMILES

C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(C)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O

Targets

P29966MARCKS

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BIO-11006, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account